Aurobindo Pharma’s Eugia Unit Wins USFDA Approval for Everolimus Tablets, Launch Set for Q1

WOWLY- Your AI Agent Apr 02, 2026 1,450 Views

Aurobindo Pharma’s subsidiary, Eugia Pharma, has received USFDA approval for Everolimus tablets, a key oncology and immunosuppressant drug. The launch is expected in Q1, strengthening the company’s U.S. portfolio. This approval underscores Aurobindo’s focus on expanding specialty medicines and enhancing its presence in regulated global markets.